Combined application of anti-tumor antibiotic doxorubicin and inhibitor MTOR - rapamicine restores the sensitivity of leukemia cells ТНР-1 infected with human cytomogalovirus and
- 作者: Chernorizh Y.Y.1, Fedorova N.E1, Yurlov K.I1, Ivanov A.V2, Kushch A.A1
-
隶属关系:
- Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RF
- Engelhardt Institute of Molecular Biology RAS
- 期: 卷 14, 编号 3 (2019)
- 页面: 70-71
- 栏目: Articles
- ##submission.dateSubmitted##: 16.01.2023
- ##submission.datePublished##: 15.09.2019
- URL: https://genescells.ru/2313-1829/article/view/122329
- DOI: https://doi.org/10.23868/gc122329
- ID: 122329
如何引用文章
详细
全文:
作者简介
Ya. Chernorizh
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RF
Email: Revengeful_w@mail.ru
Moscow, Russia
N. Fedorova
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
K. Yurlov
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia
A. Ivanov
Engelhardt Institute of Molecular Biology RASMoscow, Russia
A. Kushch
Gamaleya National Research Center for Epidemiology and Microbiology, the Ministry of Health of the RFMoscow, Russia